Illumina Body Map 2 (GSE30611)
Name | miRBASE accession |
---|---|
hsa-miR-375
|
MIMAT0000728 |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr17_+_40443441 Show fit | 1.13 |
ENST00000269593.5
|
insulin like growth factor binding protein 4 |
|
chr18_+_22169580 Show fit | 0.86 |
ENST00000269216.10
|
GATA binding protein 6 |
|
chr11_+_102110437 Show fit | 0.73 |
ENST00000282441.10
ENST00000526343.5 ENST00000537274.5 ENST00000345877.6 ENST00000615667.4 |
Yes1 associated transcriptional regulator |
|
chr12_+_20368495 Show fit | 0.72 |
ENST00000359062.4
|
phosphodiesterase 3A |
|
chr1_-_56579555 Show fit | 0.59 |
ENST00000371250.4
|
phospholipid phosphatase 3 |
|
chr9_-_16870662 Show fit | 0.56 |
ENST00000380672.9
|
basonuclin 2 |
|
chr11_-_115504389 Show fit | 0.54 |
ENST00000545380.5
ENST00000452722.7 ENST00000331581.11 ENST00000537058.5 ENST00000536727.5 ENST00000542447.6 |
cell adhesion molecule 1 |
|
chr3_-_151461011 Show fit | 0.54 |
ENST00000282466.4
|
immunoglobulin superfamily member 10 |
|
chr2_-_227164194 Show fit | 0.45 |
ENST00000396625.5
|
collagen type IV alpha 4 chain |
|
chr2_+_66435558 Show fit | 0.44 |
ENST00000488550.5
|
Meis homeobox 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.1 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.1 | 1.0 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.2 | 0.9 | GO:0032912 | negative regulation of transforming growth factor beta2 production(GO:0032912) |
0.0 | 0.8 | GO:0072257 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.1 | 0.7 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.0 | 0.6 | GO:0008354 | germ cell migration(GO:0008354) |
0.0 | 0.6 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.1 | 0.5 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.0 | 0.5 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.4 | GO:0060458 | right lung development(GO:0060458) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.7 | GO:0071149 | TEAD-1-YAP complex(GO:0071148) TEAD-2-YAP complex(GO:0071149) |
0.0 | 0.5 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.1 | 0.4 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.0 | 0.4 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 0.1 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.0 | 0.1 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.0 | 0.1 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.1 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.0 | 1.1 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.8 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.2 | 0.7 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
0.1 | 0.6 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.1 | 0.4 | GO:1904928 | coreceptor activity involved in canonical Wnt signaling pathway(GO:1904928) |
0.0 | 0.4 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.0 | 0.3 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.2 | GO:0016524 | latrotoxin receptor activity(GO:0016524) |
0.0 | 0.2 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.9 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.7 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |